629
Views
10
CrossRef citations to date
0
Altmetric
Drug profile

Subcutaneous tocilizumab for the treatment of rheumatoid arthritis

&
Pages 103-114 | Received 24 Sep 2015, Accepted 30 Nov 2015, Published online: 28 Jan 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Piero Ruscitti, Paola Cipriani, Paola Di Benedetto, Vasiliky Liakouli, Francesco Carubbi, Onorina Berardicurti, Francesco Ciccia, Giuliana Guggino, Giovanni Triolo & Roberto Giacomelli. (2017) Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets?. Expert Review of Clinical Immunology 13:11, pages 1041-1047.
Read now

Articles from other publishers (9)

Gaurav Doshi & Ami Thakkar. (2021) Deciphering Role of Cytokines for Therapeutic Strategies Against Rheumatoid Arthritis. Current Drug Targets 22:7, pages 803-815.
Crossref
Yukihiro Kitanaga, Emiko Imamura, Yutaka Nakahara, Hidehiko Fukahori, Yasutomo Fujii, Satoshi Kubo, Shingo Nakayamada & Yoshiya Tanaka. (2020) In vitro pharmacological effects of peficitinib on lymphocyte activation: a potential treatment for systemic sclerosis with JAK inhibitors. Rheumatology 59:8, pages 1957-1968.
Crossref
Maria Antonietta Barbieri, Giuseppe Cicala, Paola Maria Cutroneo, Elisabetta Gerratana, Caterina Palleria, Caterina De Sarro, Ada Vero, Luigi Iannone, Antonia Manti, Emilio Russo, Giovambattista De Sarro, Fabiola Atzeni & Edoardo Spina. (2020) Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study. Journal of Clinical Medicine 9:4, pages 1227.
Crossref
Raimon Sanmarti, Douglas J. Veale, Emilio Martin‐Mola, Alejandro Escudero‐Contreras, Carlos González, Liliana Ercole, Rocío Alonso, João E. Fonseca, Cristina Alcañiz, José María Álvaro‐Gracia, Alejandro Balsa, José Luis Pablos, Consuelo Díaz Miguel, José Manuel Rodríguez, Jose Alves, Elena Aurrecoechea, Jaime Calvo, Joaquín Belzunegui, Francisco Blanco, Rafael Caliz, Javier Calvo, José Román Ivorra, Helena Canhão, Helena Santos, Eugenio Chamizo, Javier Pino, Concepción Delgado, César Díaz, Antonio Fernández Nebro, Alexander Fraser, Antonio Gomez, Blanca Hernández, Federico Navarro, Juan Povedano, Antonio Juan Mas, David Kane, Bryan Whelan, Carlos Marras, Juan Moreno, José Pérez Venegas, Manuel Pombo, Elena Riera, Antonio Rosas, John Ryan, José Santos, Maria Santos, Jesús Tornero, Juan Víctor Tovar, Eduardo Ucar, Carlos Vasconcelos, Raúl Veiga & Paloma Vela. (2019) Reducing or Maintaining the Dose of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis in Clinical Remission: A Randomized, Open‐Label Trial. Arthritis & Rheumatology 71:10, pages 1616-1625.
Crossref
Gang Fang, Qinghuai Zhang, Yuzhou Pang, Hnin Ei Thu & Zahid Hussain. (2019) Nanomedicines for improved targetability to inflamed synovium for treatment of rheumatoid arthritis: Multi-functionalization as an emerging strategy to optimize therapeutic efficacy. Journal of Controlled Release 303, pages 181-208.
Crossref
Marina Mesquida, Victor Llorenç & Alfredo Adán. 2019. Treatment of Non-infectious Uveitis. Treatment of Non-infectious Uveitis 95 112 .
Graeme Jones & Elena Panova. (2018) New insights and long-term safety of tocilizumab in rheumatoid arthritis. Therapeutic Advances in Musculoskeletal Disease 10:10, pages 195-199.
Crossref
Marina Mesquida, Blanca Molins, Víctor Llorenç, Maite Sáinz de la Maza & Alfredo Adán. (2017) Targeting interleukin-6 in autoimmune uveitis. Autoimmunity Reviews 16:10, pages 1079-1089.
Crossref
R. Goswami & M.H. Kaplan. 2017. 123 180 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.